Abstract

In a large US multicentre database, the STS-PROM performs better than EuroSCORE II for CABG. However, EuroSCORE II is a reasonable alternative in low-risk CABG patients and in those undergoing other cardiac surgical procedures. Clinical trials and physicians that use these scores recruit and treat patients who are at a lower risk than anticipated. This potentially leads to overtreatment with an investigational device. Decision-making should not solely be based on risk scores, but should comprise multidisciplinary heart team discussions.

Keywords

EuroSCOREMedicinePromCardiologyAortic valve replacementInternal medicineReceiver operating characteristicCohortCardiac surgeryStenosis

Affiliated Institutions

Related Publications

Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval

Nicolò Piazza , Eberhard Grube , Ulrich Gerckens +10 more

The results of this study demonstrate the high rate of procedural success and a low 30-day mortality in a large cohort of high-risk patients undergoing transcatheter aortic valv...

2008 EuroIntervention 629 citations

Publication Info

Year
2014
Type
article
Volume
46
Issue
3
Pages
400-408
Citations
119
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

119
OpenAlex

Cite This

Ruben L.J. Osnabrugge, Alan M. Speir, Stuart J. Head et al. (2014). Performance of EuroSCORE II in a large US database: implications for transcatheter aortic valve implantation. European Journal of Cardio-Thoracic Surgery , 46 (3) , 400-408. https://doi.org/10.1093/ejcts/ezu033

Identifiers

DOI
10.1093/ejcts/ezu033